Evidence map›Paper›PMID 25821492›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2015

Inhibitory Effects of Chemical Compounds Isolated from the Rhizome of Smilax glabra on Nitric Oxide and Tumor Necrosis Factor- α Production in Lipopolysaccharide-Induced RAW264.7 Cell.

Chuan-Li Lu, Wei Zhu, Dong-Mei Wang, Wen-Long Chen, Meng-Mei Hu, Min Wang, Xiao-Jie Xu, Chuan-Jian Lu

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Pharmaceutics · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cytotoxic Compounds fromMolecules (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
  10. Drug design, development and therapy · 2022
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chuan-Li LuThe Second Institute of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510120, China ; Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510120, China ; Postdoctoral Research Station, Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
Wei ZhuThe Second Institute of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510120, China ; Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510120, China.
Dong-Mei WangThe Second Institute of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510120, China ; Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510120, China.
Wen-Long ChenThe Second Institute of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
Meng-Mei HuThe Second Institute of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
Min WangThe Second Institute of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
Xiao-Jie XuThe Second Institute of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510120, China ; Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510120, China.
Chuan-Jian LuThe Second Institute of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510120, China ; Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510120, China.ORCID 0000-0001-6531-0702

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rhizome of Smilax glabra has been used for a long time as both food and folk medicine in many countries. The present study focused on the active constituents from the rhizome of S. glabra, which possess potential anti-inflammatory activities. As a result, nine known compounds were isolated from the rhizome of S. glabra with the bioassay-guiding, and were identified as syringaresinol (1), lasiodiplodin (2), de-O-methyllasiodiplodin (3), syringic acid (4), 1,4-bis(4-hydroxy-3,5-dimethoxyphenyl)-2,3-bis(hydroxymethyl)-1,4-butanediol (5), lyoniresinol (6), trans-resveratrol (7), trans-caffeic acid methyl ester (8), and dihydrokaempferol (9). Among these compounds, 2 and 3 were isolated for the first time from S. glabra. In addition, the potential anti-inflammatory activities of the isolated compounds were evaluated in vitro in lipopolysaccharide- (LPS-) induced RAW264.7 cells. Results indicated that 4 and 7 showed significant inhibitory effects on NO production of RAW264.7 cells, and 1, 2, 3, and 5 showed moderate suppression effects on induced NO production. 1, 7, and 5 exhibited high inhibitory effects on TNF-α production, with the IC50 values less than 2.3, 4.4, and 16.6 μM, respectively. These findings strongly suggest that compounds 1, 2, 3, 4, 5, 7, and 9 were the potential anti-inflammatory active compositions of S. glabra.

Identifiers

PMID25821492
PMCPMC4363603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.